Blood Cancer UK: Pilot Grants

Overview

Innovative Pilot Grants

Blood Cancer UK’s Innovative Pilot Grant scheme for 2024-2025 is now open.

This scheme supports researchers with novel research ideas in areas related to blood cancer develop the pilot data needed to secure further investment from our other grant schemes, other medical research funders or industry. This scheme allows them to fund innovative research ideas that could lead to the next big breakthroughs in blood cancer research.

Remit

Pilot grants are awarded for up to £30,000 for a duration of up to 12 months.

They invite applications for innovative research projects which aim to develop pilot data in novel areas of research with the potential to impact the understanding, prevention, diagnosis, treatment or management of blood cancer.

Early career researchers in particular are encouraged to apply.

Applicants should clearly outline the potential impact for people affected by blood cancer.

Eligibility

Individuals based at UK universities, hospitals or other recognised research institutions who are able to sign up to Blood Cancer UK’s Terms and Conditions are eligible to apply.

Applicants should have at minimum some postdoctoral research experience, or equivalent, and be scientists, clinicians or healthcare professionals. Early career researchers are especially encouraged to apply, this includes both independent early career researchers with access to their own lab space, and current postdocs aiming to develop the pilot data required for further research or fellowship applications. Early career researchers and postdocs must include a letter of support for both them as an individual and for the project from the head of the lab or department in which they are working. They can also include letters of support from any other relevant mentors. Any early career researchers currently undertaking fellowships must also clearly outline how they will deliver this pilot grant alongside their existing fellowship project.